{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,22]],"date-time":"2024-07-22T10:36:11Z","timestamp":1721644571053},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1097\/mbc.0b013e32835a8aca","type":"journal-article","created":{"date-parts":[[2012,12,13]],"date-time":"2012-12-13T08:09:54Z","timestamp":1355386194000},"page":"71-75","source":"Crossref","is-referenced-by-count":6,"title":["The expression and concentration of CD40 ligand in normal pregnancy, preeclampsia, and hemolytic anemia, elevated liver enzymes and low platelet count (HELLP) syndrome"],"prefix":"10.1097","volume":"24","author":[{"given":"Hanan A.G.","family":"Azzam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nashwa K.","family":"Abousamra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hossam","family":"Goda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reda","family":"El-Shouky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdel-Hady","family":"El-Gilany","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-12-20210203","first-page":"S1","article-title":"Am J Obstet G","volume":"183","year":"2000","journal-title":"ynecol"},{"key":"R3-12-20210203","first-page":"1261","article-title":"A case of aggravation of hemolytic anemia, elevated liver enzymes and low platelet count syndrome after delivery.","volume":"124","author":"Jiang","year":"2011","journal-title":"Chin Med J"},{"key":"R4-12-20210203","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1515\/JPM.2002.076","article-title":"Clinical and biophysical aspects of HELLP-syndrome.","volume":"30","author":"Ertan","year":"2002","journal-title":"J Perinat Med"},{"key":"R5-12-20210203","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1093\/qjmed\/95.6.343","article-title":"Severe hepatic dysfunction in pregnancy.","volume":"95","author":"Rahman","year":"2002","journal-title":"QJM"},{"key":"R6-12-20210203","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1055\/s-0038-1649882","article-title":"Flow cytometric detection of activated platelets in pregnant women prior to the development of preeclampsia.","volume":"74","author":"Janes","year":"1995","journal-title":"Thromb Haemost"},{"key":"R7-12-20210203","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/j.ajog.2003.10.699","article-title":"Different levels of platelet activation in preeclamptic, normotensive pregnant, and nonpregnant women.","volume":"190","author":"Holthe","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"R8-12-20210203","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/S0002-9378(97)70212-6","article-title":"Can flow cytometric detection of platelet activation early in pregnancy predict the occurrence of preeclampsia A prospective study.","volume":"177","author":"Konijnenberg","year":"1997","journal-title":"AmJ Obstet Gynecol"},{"key":"R9-12-20210203","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1161\/01.RES.0000252802.25497.b7","article-title":"Platelets as immune cells: bridging inflammation and cardiovascular disease.","volume":"100","author":"Von Hundelshausen","year":"2007","journal-title":"Circ Res"},{"key":"R10-12-20210203","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1161\/01.RES.0000074030.98009.FF","article-title":"CD40-CD40L and platelet function: beyond hemostasis.","volume":"92","author":"Freedman","year":"2003","journal-title":"Circ Res"},{"key":"R11-12-20210203","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/35393","article-title":"CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells.","volume":"391","author":"Henn","year":"1998","journal-title":"Nature"},{"key":"R12-12-20210203","first-page":"4","article-title":"The CD40CD154receptorligand dyad.","volume":"58","author":"Schonbeck","year":"2001","journal-title":"Cell Mol Life Sci"},{"key":"R13-12-20210203","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1159\/000006940","article-title":"CD40L activation in circulating platelets in patient with acute coronary syndrome.","volume":"92","author":"Lee","year":"1999","journal-title":"Cardiology"},{"key":"R14-12-20210203","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1182\/blood.V98.4.1047","article-title":"The inflammatory action of CD40 ligand (CD 154) expressed on activated human platelets is temporally limited by coexpressed CD40.","volume":"98","author":"Henn","year":"2001","journal-title":"Blood"},{"key":"R15-12-20210203","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1161\/01.CIR.96.2.396","article-title":"Activation of monocytemacrophage functions related to acute atheroma complication by ligation of CD40: induction of collagenase, stromelysin, and tissue factor.","volume":"96","author":"Mach","year":"1997","journal-title":"Circulation"},{"key":"R16-12-20210203","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1172\/JCI200113620","article-title":"Upregulation of TRAF-3 by shear stress blocks CD40 mediated endothelial activation.","volume":"108","author":"Urbich","year":"2001","journal-title":"J Clin Invest"},{"key":"R17-12-20210203","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1159\/000098316","article-title":"sCD40 ligand determined in maternal and umbilical cord blood in pregnancies complicated by preeclampsia with and without intrauterine growth retardation.","volume":"64","author":"Laskowska","year":"2007","journal-title":"Gynecol Obstet Invest"},{"key":"R18-12-20210203","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1177\/1076029606299076","article-title":"Increased concentration of soluble CD40 ligand in preeclampsia.","volume":"13","author":"Alacacioglu","year":"2007","journal-title":"Clin Appl Thromb Hemost"},{"key":"R19-12-20210203","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1097\/01.AOG.0000206206.99212.9e","article-title":"Serum-soluble CD40 ligand in normal pregnancy and in preeclampsia.","volume":"107","author":"Oron","year":"2006","journal-title":"Obstet Gynecol"},{"key":"R20-12-20210203","first-page":"2317","article-title":"Diagnosis and management of preeclampsia.","volume":"70","author":"Wagner","year":"2004","journal-title":"Am Fam Physician"},{"key":"R21-12-20210203","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/0002-9378(89)90665-0","article-title":"Preeclampsia: an endothelial cell disorder.","volume":"161","author":"Roberts","year":"1989","journal-title":"Am J Obstet Gynecol"},{"key":"R22-12-20210203","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2174\/1567270043405240","article-title":"Interaction between platelets and cytokines- a possible role in the pathogenesis of preeclampsia.","volume":"1","author":"Bar","year":"2004","journal-title":"Vasc Dis Prev"},{"key":"R23-12-20210203","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.ijgo.2009.01.034","article-title":"Upregulation of the CD40-CD40 ligand system in preeclampsia.","volume":"105","author":"Lukanov","year":"2009","journal-title":"Int J Gynaecol Obstet"},{"key":"R24-12-20210203","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1161\/01.CIR.0000028962.04520.01","article-title":"Platelet-derived CD40L: the switch-hitting player of cardiovascular disease.","volume":"106","author":"Andre","year":"2002","journal-title":"Circulation"},{"key":"R25-12-20210203","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1038\/15271","article-title":"Requirement for CD154 in the progression of atherosclerosis.","volume":"5","author":"Lutgens","year":"1999","journal-title":"Nat Med"},{"key":"R26-12-20210203","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1161\/01.RES.0000070111.98158.6C","article-title":"CD40 is constitutively expressed on platelets and provides a novel mechanism for platelet activation.","volume":"92","author":"Inwald","year":"2003","journal-title":"Circ Res"}],"container-title":["Blood Coagulation & Fibrinolysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MBC.0b013e32835a8aca","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:30:53Z","timestamp":1620959453000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00001721-201301000-00012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/mbc.0b013e32835a8aca","relation":{},"ISSN":["0957-5235"],"issn-type":[{"value":"0957-5235","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]}}}